preclinical white papers and articles

  1. Toxicokinetics, Pharmacokinetics, And Pharmacodynamics 11/20/2024

    Discover why gathering and analyzing pharmacokinetic (PK) and pharmacodynamic (PD) data is key — from preclinical studies right to clinical trial conduct.

  2. Overview Of Bladder Cancer: Global Clinical Trials Landscape 11/15/2024

    Advances in immunotherapy, targeted drugs, and clinical trials are improving outcomes for bladder cancer patients, addressing regional disparities and accessibility challenges worldwide.

  3. Overview Of Small Cell Lung Cancer: Global Clinical Trial Landscape 11/15/2024

    Small cell lung cancer (SCLC) is a fast-growing, aggressive lung cancer subtype. Global incidence, innovative therapies, and personalized medicine are transforming treatment outcomes and survival rates.

  4. Overview Of Diffuse Large B-cell Lymphoma: Global Clinical Trial Landscape 11/15/2024

    Diffuse large B-cell lymphoma (DLBCL), the most common non-Hodgkin lymphoma subtype, has varied molecular profiles, global incidence, innovative drugs, and trials improving treatment strategies and patient outcomes.

  5. Bladder Cancer Global Clinical Trial Landscape (2024) 11/12/2024

    Bladder cancer is the ninth most common cancer in the world and thirteenth in mortality. This report provides a detailed overview of the clinical trial landscape for bladder cancer.

  6. QT Monitoring Impacts More Than Just Cardiac Health 10/25/2024

    Achieve earlier detection of potential adverse cardiac events and refine patient selection for future trial phases by implementing advanced QT monitoring tools.

  7. Bispecific Antibody PK And ADA Bioanalysis: An Experienced Approach 10/16/2024

    This article outlines a strategic approach to address these bioanalytical challenges for BsAbs, ensuring accurate and reliable assessment of safety and efficacy.

  8. Cervical Cancer - Global Clinical Trial Landscape (2024) 10/15/2024

    Expand your understanding of the cervical cancer (CC) clinical trial landscape, including current drug development funding, and the effect of this disease on the world.

  9. Bedside-To-Bench-To-Bedside Collaboration 9/18/2024

    Explore how the partnerships between cutaneous T-cell lymphoma (CTCL) patients, physicians, and researchers is leading to advancements in diagnosing and managing this life-threatening disease.

  10. A New Pharmacovigilance Ecosystem: Automation, AI, And Continuous Improvement 9/18/2024

    As Pharmacovigilance (PV) evolves into a proactive, value-driven discipline innovations like robotic process automation and artificial intelligence help improve efficiency and data utility.